[en] To accurately estimate the incidence of HOX11L2 expression, and determine the associated cytogenetic features, in T-cell acute lymphoblastic leukemia (T-ALL), the Groupe Francais de Cytogenetique Hematologique (GFCH) carried out a retrospective study of both childhood and adult patients. In total, 364 patients were included ( 211 children less than or equal to15 years and 153 adults), and 67 ( 18.5%) [ 47 children ( 22.4%) and 20 adults (13.1%)] were shown to either harbor the t(5; 14) q35; q32) translocation or express the HOX11L2 gene or both. Most of the common hematological parameters did not show significant differences within positive and negative populations, whereas the incidence of CD1a+/CD10+ and cytoplasmic CD3+ patients was significantly higher in positive than in negative children. Out of the 63 positive patients investigated by conventional cytogenetics, 32 exhibited normal karyotype, whereas the others 31 showed clonal chromosome abnormalities, which did not include classical T-ALL specific translocations. Involvement of the RANBP17/HOX11L2 locus was ascertained by fluorescence in situ hybridization in six variant or alternative (three-way translocation or cytogenetic partner other than 14q32) translocations out of the 223 patients. Our results also show that HOX11L2 expression essentially occurs as a result of a 5q35 rearrangement, but is not associated with another identified T-ALL specific recurrent genetic abnormality, such as SIL-TAL fusion or HOX11 expression.
Disciplines :
Oncology Hematology
Author, co-author :
Berger, R.
Dastugue, N.
Busson, M.
van den Akker, J.
Perot, C.
Ballerini, P.
Hagemeijer, A.
Michaux, L.
Charrin, C.
Pages, M. P.
Mugneret, F.
Andrieux, J.
Talmant, P.
Helias, C.
Mauvieux, L.
Lafage-Pochitaloff, M.
Mozziconacci, M. J.
Cornillet-Lefebvre, P.
Radford, I.
Asnafi, V.
Bilhou-Nabera, C.
Khac, F. N.
Leonard, C.
Speleman, F.
Poppe, B.
Bastard, C.
Taviaux, S.
Quilichini, B.
Herens, Christian ; Centre Hospitalier Universitaire de Liège - CHU > PLAN COS
Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995; 85: 3662-3670.
Jaju RJ, Haas OA, Neat M, Harbott J, Saha V, Boultwood J et al. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. Blood 1999; 94: 773-780.
Bernard OA, Busson-Le Coniat M, Ballerini P, Mauchauffé M, Della Valle V, Monni R et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001; 15: 1495-1504.
Hélias C, Leymarie V, Entz-Werle N, Falkenrodt A, Eyer D, Aurich-Costa J et al. Translocation t(5;14)(q35;q32) in 3 cases of childhood T-cell acute lymphoblastic leukemia: a new recurring and cryptic abnormality. Leukemia 2002; 16: 7-12.
Dubé ID, Kamel-Reid S, Yuan CC, Lu M, Wu X, Corpus G et al. A novel homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). Blood 1991; 78: 2996-3003.
Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 1991; 253: 79-82.
Vilmer E, Suciu S, Ferster A, Bertrand Y, Cavé H, Thyss A et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Leukemia 2000; 14: 2257-2266.
Donadieu J, Auclerc MF, Baruchel A, Perel Y, Bordigoni P, Landman-Parker J et al. Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE). Br J Cancer 2000; 83: 1617-1622.
Dombret H, Gabert J, Boiron J-M, Rigal-Huret F, Blaise D, Thomas X et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia - results of the prospective multicenter LALA-94 trial. Blood 2002; 100: 2057-2066.
European Group for the Immunological Characterization of Leukemias. (EGIL): Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783-1786.
ISCN 1995. An Intemational System for Human Cytogenetic Nomenclature. In: Mitelman F (ed). Basel, Switzerland: Karger, 1995.
Ballerini P, Blaise A, Busson-Le Coniat M, So X-Y, Zucman-Rossi J, Adam M et al. Hox11L2 expression defines a clinical subtype of pediatrc T-ALL associated with poor prognostic. Blood 2002; 100: 991-997.
Mauvieux L, Leymarie V, Helias C, Perusson N, Falkenrodt A, Lioure B et al. High incidence of HOX11L2 expression in children with T-ALL. Leukemia 2002; 16: 2417-2422.
Whitlock JA, Raimondi SC, Harbott J, Morris SW, McCurley TL, Hansen-Hagge TE et al. t(5;14)(q33-34;q11), a new recurring cytogenetic abnormality in childhood acute leukemia. Leukemia 1994; 8: 1539-1543.
Hansen-Haage TE, Schäfer M, Kiyoi H, Morris SW, Whitlock JA, Koch P et al. Disruption of the RanbBP17/Hox11L2 region by recombination with the TCRd locus in acute lymphoblastic leukemias with t(5;14)(q34;q11). Leukemia 2002; 16: 22205-22212.
Begley CG, Green AR. The SCL gene: from case report to critical hematopoietic regulator. Blood 1999; 93: 1760-1770.
Aplan PD, Johnson BE, Russell E, Chervinsky DS, Kirsch IR. Cloning and characterization of TCTA, a gene located at the site of a t(1;3) translocation. Cancer Res 1995; 55: 1917-1921.
Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.